1 / 9

Global Respiratory Drugs Market Forecast to 2024

The “Global Respiratory Drugs Market” is estimated to witness a CAGR of 5.9% during the forecast period 2018-2024. The respiratory drugs market is analyzed based on two segments – Applications and Regions.

infoholicresearch
Télécharger la présentation

Global Respiratory Drugs Market Forecast to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Respiratory Drugs Market Report Forecasts to 2024 Global Respiratory Drugs Market 2018-2024 https://www.infoholicresearch.com/report/respiratory-drugs-market-2018-2024/

  2. Report Overview Pulmonary medicine is the branch of medical science that deals with diagnosis, prevention, and treatment of diseases affecting the respiratory system. The conditions included are acute respiratory distress syndrome, sarcoidosis of the lungs, asthma, chronic obstructive pulmonary disease, lung cancer, occupational lung disease, pulmonary hypertension, tuberculosis, cystic fibrosis, interstitial lung disease, lung transplants, and severe acute respiratory syndrome. The intensity of competition in the respiratory drug market is high with few players dominating the market. The heavy investments made in the development of respiratory drug delivery systems have favored the growth of the market. The entry of innovative and effective drugs in the market is expected to drive the future of the market. Short-Acting Beta2-Agonists (SABA), Inhaled corticosteroids (ICS), anticholinergics, long-acting beta2-agonists (LABA), antihistamines, vasodilators, combination drugs, and others are the major respiratory drugs classes available in the market. Currently, the combination drugs are mainly driving the market, with top brands facing no real competition from generic alternatives. The emergence of inexpensive, state-of-the-art and effective drug delivery devices will stimulate the market growth. Buy Complete Report: https://www.infoholicresearch.com/report/respiratory-drugs-market-2018-2024/

  3. Key Players Novartis AG, GlaxoSmithKline plc, Astra Zeneca PLC., F. Hoffmann-La Roche Ltd, and Vertex Pharmaceuticals Inc are the key players in the market. Mylan, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Limited, Gilead Sciences, Inc, Bayer AG, Pfizer Inc., Bristol-Myers Squibb, Merck & Co., Sanofi, and Mallinckrodt plc are some of the other prominent respiratory drugs manufacturers in the market. Market Analysis: ` The “Global Respiratory Drugs Market” is estimated to witness a CAGR of 5.9% during the forecast period 2018-2024. The respiratory drugs market is analyzed based on two segments – Applications and Regions. 113 Pages|32 Tables |42 Charts |14 Companies | 10 Enquiry Hours Get Sample Report https://www.infoholicresearch.com/request-a-sample-report/?repid=9841

  4. 10% Free Customization On This Report • https://www.infoholicresearch.com/request-a-sample-report/?repid=9841 • https://www.infoholicresearch.com/engage-with-analyst/?repid=9841 • https://www.infoholicresearch.com/customize-sample/?repid=9841 • https://www.infoholicresearch.com/enquiry-before-buying/?repid=9841

  5. Competitive Analysis Business partnerships, merger & acquisitions and a multifaceted pipeline are the major strategies of the market players. In March 2017, AstraZeneca and SenzaGen collaborated to develop genomic methods for respiratory allergens. In December 2016, Novartis out-licensed its three COPD products UtibronNeohaler, SeebriNeohaler and ArcaptaNeohaler to Sunovion Pharmaceuticals. In March 2017, Sanofi invested $147 million in AstraZeneca’s drug for preventing respiratory syncytial virus (RSV) infections. This gave equal share in costs and profits for both the companies. Regional Analysis The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America accounts for the largest share of the global respiratory drugs market, followed by Europe, Asia Pacific, and Rest of the World. More than 60% of the market is occupied by North America, with the US being the major contributor to the market growth. 113 Pages|32 Tables |42 Charts |14 Companies | 10 Enquiry Hours Get Sample Report https://www.infoholicresearch.com/request-a-sample-report/?repid=9841

  6. Methodology Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps: Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

  7. About Infoholic Research Infoholic Research(https://www.infoholicresearch.com/)is a global market research and consulting organization providing strategic and high-level market intelligence in emerging and niche markets in Healthcare, ICT, Semiconductors, Chemicals & Materials domain. We aim at delivering high-quality results to our clients providing them with in-depth industry insights to identify new business opportunities and nurture their business strategies. Our team of analysts spanning verticals such as ICT, Healthcare, Chemicals and Semiconductors creates extensive Market Research reports every month covering market trends and dynamics envisioning the road ahead. We also have a Newsletter wherein we keep on featuring guest columns from domain experts, tête-à-tête with leaders and likewise. Additionally, our insightful blogs and articles truly keep the readers hooked. You may also send in your requests for getting our analysts’ viewpoints in specific areas of Healthcare, ICT, Chemicals & Materials, and Semiconductors to validate a certain market trend/ insight or finding. Please let me know how we both can create a cohesive quotient and associate for creating a win-win situation for both of us. https://www.infoholicresearch.com/report/respiratory-drugs-market-2018-2024/

  8. Contact Us Infoholic Research45/1, Residency Road Cross,5th Floor, Leo Shopping Complex, Bengaluru – 560025, IndiaEmail: sales@infoholicresearch.com Linkedin: https://www.linkedin.com/company/infoholic-research/ https://www.infoholicresearch.com/report/respiratory-drugs-market-2018-2024/

More Related